Transforming Toxicity Assessment through Microphysiology, Bioprinting, and Computational Modeling
Journal Title: Advances in Clinical Toxicology - Year 2024, Vol 9, Issue 1
Abstract
Background:Traditional toxicity testing emphasizes animal models with growing concerns regarding predictive capacity, throughput and ethics. Rapid innovation surrounding human cell platforms, bioengineered tissues, omics techniques and computational tools offers more modern alternatives aligned with expanding knowledge of chemical biological pathways. These disruptive approaches promise immense potential to transform next-generation chemical safety assessment and drug development pipelines. Purpose: This review provides clinical researchers an updated, comprehensive perspective across evolving areas of focus in new toxicity testing methods with analysis of latest advances and translational context. Main Body: We survey progress in two- and three-dimensional human cell cultures recapitulating tissue/organ complexity impossible in conventional assays. Complementing this, computational modeling integrates structure-activity relationships, physicochemical properties and physiological interactions to predict pharmacokinetics and toxicity in silico. Expanding model organisms add further dimensionality and demographic relevance. High-throughput omics and imaging technologies unravel mechanisms and illuminate biomarkers undetectable by standard measures. Specialized techniques show high promise addressing toxicodynamic intricacies within disease contexts like diabetes and NAFLD. Evaluating traditional medicines and expanding phytochemicals likewise represents an area of growth well-suited for contemporary platforms. Future outlook weighs remarkable potential advantages in reducing animal testing demands, enabling precision toxicology links to clinical medicine and overhauling core chemical risk assessment frameworks. Conclusion: This review intends to catalyze discourse on strategic optimization priorities and roadmaps towards fully unlocking the immense yet still emerging public health potential of these disruptive techniques poising transformation in toxicity sciences centered on human-focused models.
Authors and Affiliations
Tamer A Addissouky , Yuliang Wang , Ibrahim El Tantawy El Sayed , Majeed MAA and Ahmed A Khalil
Keywords
Related Articles
- EP ID EP754424
- DOI 10.23880/act-16000295
- Views 5
- Downloads 0
Biochemical Effect of Artemisin-based Combination Therapy (ACT) Antimalarial Drugs on Enzymatic Antioxidants in Pregnancy
This study was undertaken to determine the effect of artemisin-based combination therapy (ACT) on Plasma enzymatic antioxidants in pregnant women with malaria. Seventy-five (75) consenting pregnant subjects (25malarial...
Addiction and Evolutionary Process, Common Aspects in Physio-Pathologic Pathways Useful in Pharmaco-Toxicological Approach
Observing vertebrates evolutionary in mammalian are present characteristic pathways involved in progeny take care in first period after birth. In this behavior and instinct, learning neuronal circuits are evolved and re...
The Toxic versus Therapeutic Interactions of Tyrosine Kinase Inhibitors and Radiation Therapy
Introduction: Progress in both the development of Tyrosine Kinase Inhibitors (TKIs) and modern radiation therapy (RT) have opened new horizons for the safe and effective treatments of cancer. Combination therapies of TK...
Cardiovascular Complications during COVID-19 Infection
In December 2019 a serious outbreak of pneumonia emerged in china. The infection Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), spreads the infection rapidly...
Bioremediation of Industrial Effluents by Alkaliphilic Bacteria Isolated from Marine Ecosystems
Alkaliphilic bacteria are a diverse group of microorganisms capable of surviving at high pH. Industrial pollutants are mainly present in industrial waste effluents which have a high pH. Therefore employing alkaliphiles...